drugset / Trial / NCT00891228
Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men
Phase 1
Completed
99 enrolled
Premier Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · collabPopulation Council · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
To determine the number of men who have suppression of sperm production when using a daily regimen of Nestorone® Gel (0, 8 or 12 mg) and Testosterone Gel applied transdermally.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-05
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Segesterone Acetate | Small molecule | 0 mg | Other |
| Comparator | Segesterone Acetate | Small molecule | 8 mg | Other |
| Comparator | Segesterone Acetate | Small molecule | 12 mg | Other |
| Background | Testosterone | Small molecule | 100 mg | Other |
Indications
No indication recorded.